Here you can find the latest news and updates from EUCAST.

29 Jun 2022
Cefiderocol susceptibility testing

Warning issued concerning cefiderocol susceptibility testing: there is currently no commercially available functioning test for cefiderocol MIC determination. EUCAST has investigated those available and all have problems with...[more]

22 Jun 2022
Screening for azole and echinocandin resistance

Screening for azole and echinocandin resistanceexemplified in Aspergillus[more]

19 Jun 2022
Warning against using material and devices for AST of species not listed as validated.

General warning against incomplete species and concentration range validation of commercially available susceptibility testing material and devices: In many cases manufacturers of susceptibility testing material and...[more]

14 May 2022
Consultation (14 May - 15 June, extended to 15 July) on revised breakpoints for IV fosfomycin

EUCAST posted a general consultation on revised breakpoints for intravenous fosfomycin. Consultation period 14 May - 15 June, 2022. Revised breakpoints will be published in breakpoint table 2023.[more]

04 May 2022
Consultation on the availability of piperacillin and ticarcillin without inhibitors.

EUCAST is considering removing breakpoints for piperacillin without tazobactam and/or ticarcillin without clavulanic acid but only if these agents are no longer used. If you in your country are still using either or both of...[more]

04 May 2022
A new version of the QC table for testing of antifungal agents is available

A new version of the QC table for testing of antifungal agents is available on the website. [more]

12 Apr 2022
Cefiderocol Rationale Document updated

The Cefiderocol Rational Document has been revised. Link. [more]

Displaying results 22 to 28 out of 482